goFAT® (Structured Lipid Blend)

Evidence Level
Limited
1 Clinical Trial
3 Documented Benefits
2/5 Evidence Score

goFAT® (Compound Solutions) is a proprietary structured lipid blend combining medium-chain triglycerides (MCTs) with other functional fat sources to provide rapid-absorbing ketogenic fuel, fat-soluble nutrient delivery, and sustained energy without spiking blood glucose or insulin. Designed for ketogenic, low-carbohydrate, and performance nutrition applications where fat serves as the primary fuel substrate.

Studied Dose Per product label; typical fat blend 5–15g/day; MCT component provides rapid ketone substrate
Active Compound Proprietary structured lipid blend — MCT-based with functional fat sources; goFAT® by Compound Solutions; specific composition proprietary

Rapid ketogenic fuel and energy

MCT-rich fat blends are rapidly absorbed and transported directly to the liver via portal circulation, bypassing lymphatic chylomicron packaging. Liver MCT metabolism rapidly generates ketone bodies (BHB, AcAc) that serve as immediate brain and muscle fuel — providing fast-acting energy without glucose or insulin dependency.

Ketosis support and metabolic flexibility

goFAT® supports nutritional ketosis in low-carbohydrate dieters by providing a concentrated, clean fat source that promotes ketone production. Combined with caloric deficit, the fat blend maintains energy availability while the body adapts to fat oxidation as its primary fuel source.

Fat-soluble nutrient delivery

Structured lipid blends enhance the absorption of fat-soluble vitamins (A, D, E, K) and fat-soluble bioactives (CoQ10, curcumin, resveratrol) by providing the dietary fat matrix required for micellar solubilization and lymphatic absorption. This makes goFAT® valuable as a carrier for lipophilic nutraceuticals.

1

Portal MCT absorption and hepatic ketogenesis

Medium-chain fatty acids (C8, C10, C12) bypass the lymphatic system and are absorbed directly via portal vein to the liver — bypassing the chylomicron packaging required for long-chain fats. In the liver, MCTs undergo rapid beta-oxidation to acetyl-CoA, which is converted to ketone bodies under low-carbohydrate conditions. This metabolic pathway provides faster energy availability than long-chain fats or carbohydrates.

1
MCT Oil and Ketosis/Energy — General Evidence
PubMed

Multiple RCTs on MCT oil component as primary evidence base. Specific goFAT® blend RCT not available.

Adults in ketogenic and weight management studies.

MCT oil component (primary): Consistent evidence for increased blood ketone levels, reduced appetite, improved cognitive energy, and modest weight management support vs. LCT controls. goFAT® provides these MCT benefits in a structured lipid format with enhanced formulation characteristics.

Common Potential side effects

GI distress (nausea, diarrhea) when MCT doses introduced too rapidly — increase gradually
High caloric density — account for fat calories in total daily intake
Not suitable for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency

Important Drug interactions

Fat-soluble drug absorption — high fat intake may alter absorption of lipophilic medications; take separately
No significant pharmacokinetic drug interactions at normal supplemental doses